ClinicalTrialsFinder

Hormone Receptor Positive，HER2-negative Breast Cancer Clinical Trials in Jinan, Shandong

1 recruitingJinan, Shandong, China

Showing 1–1 of 1 trials

Recruiting
Phase 4

Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy

Locally Advanced Breast CancerHormone Receptor Positive，HER2-negative Breast Cancer
Yongsheng Wang100 enrolled1 locationNCT05809024